Boomerang Medical is a women-led bioelectronic medical company that was granted breakthrough device designation from the FDA for its bioelectronic IBD solution.
“The most fascinating aspect of this study is the possibility of managing IBD simply by stimulating the patient’s autonomic system to release anti-inflammatory mediators,” Marco Zoccali, MD, a principal investigator for the trial at Columbia, said in an April 17 press release.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
